Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene

Peptides

Volumn 17, Issue 1, 1996, Pages 67-73

  Watters, Jyoti J ^c   Swank, Michael W ^a   Wilkinson, Charles W ^b,d,e   Dorsa, Daniel M ^b,c,d,e  

^a FURMAN UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d GRECC   (United States)

^e GRECC   (United States)

Author keywords

Adrenalectomy; Aldosterone; Glucocorticoid response element; Glucocorticoids; Liver; Messenger RNA; Receptor binding; Transcriptional regulation; WRK 1 cells

Indexed keywords

ALDOSTERONE; DEXAMETHASONE; GLUCOCORTICOID; MESSENGER RNA; MIFEPRISTONE; VASOPRESSIN V1 RECEPTOR;

ADRENALECTOMY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; GENE EXPRESSION; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

ADRENAL GLANDS; ADRENALECTOMY; ALDOSTERONE; ANIMALS; ARGININE VASOPRESSIN; CELL LINE; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; KINETICS; RATS; RECEPTORS, VASOPRESSIN; RNA, MESSENGER;

ANIMALIA;

EID: 0030060444     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0196-9781(95)02085-3     Document Type: Article

References (45)

1. Agarwal, M. K. Identification and properties of mineralocorticoid receptors in relation to glucocorticoid binders in rat liver and kidney. Biochem. J. 154(3):567-575; 1976.
2. Antoni, F. Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 39:186-188; 1984.
3. Arsenijevic, Y.; Dubois-Dauphin, M.; Tribollet, E.; Manning, M.; Sawyer, W. H.; Dreifuss, J. J. Vasopressin-binding sites in the pig pituitary gland: competition by novel vasopressin antagonists suggests the existence of an unusual receptor subtype in the anterior lobe. J. Endocrinol. 141:383-391; 1994.
4. Bardon, S.; Vignon, F.; Chalbos, D.; Rochefort, H. RU486, a progestin and glucocorticoid antaonist, inhibits the growth of breast cancer cells via the progesterone receptor. J. Clin. Endocrinol. Metab. 60(4):692-697; 1985.
5. 3H]arginine vasopressin in the septum of the rat brain. Eur. J. Pharmacol. 90:155-157; 1983.
6. 3H]-lysine vasopressin to pig kidney plasma membranes. Relationship of receptor occupancy to adenylate cyclase activation. J. Biol. Chem. 248:5922-5931; 1973.
7. Boer, R.; Crause, P.; Fahrenholz, F. Solubilization of ligand stabilized vasopressin receptors from plasma membranes of bovine kidney and rat liver. Biochim. Biophy. Res. Commun. 116(1):91-98; 1983.
8. 2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels. Neuropeptides 27:63-74; 1994.
9. Burnard, D. M.; Pittman, Q. J.; Veale, W. L. Brattleboro rats display increased sensitivity to arginine vasopressin-induced motor disturbances. Brain Res. 342:316-332; 1985.
10. 1a vasopressin receptors by glucocorticoids. Am. J. Physiol. 263:E1054-E1062; 1992.
11. Cooper, K. E.; Kasting, N. W.; Lederis, K.; Veale, W. L. Evidence supporting a role for endogenous vasopressin in the natural suppression of fever in the sheep. J. Physiol. 295:33-45; 1979.
12. DeVries, G. J.; Buijs, R. M.; Van Leeuwen, F. W.; Caffe, A. R.; Swaab, D. F. The vasopressinergic innervation of the brain in normal and castrated rats. J. Comp. Neurol. 233:236-254; 1985.
13. DeWied, D. Longterm effects of vasopressin on the maintenance of a conditioned avoidance response in rats. Nature 232:58-62; 1971.
14. DeWied, D. Central actions of neurohypophyseal hormones: The neurohypophysis: Structure, function and control. Prog. Brain Res. 60:155-167; 1983.
15. DeWied, D. The neuropeptide concept. Prog. Brain Res. 72:93-109; 1987.
16. Dorsa, D. M.; Brot, M.; Shewey, L. M.; Meyers, K. M.; Szot, P.; Miller, M. A. Interaction of a vasopressin antagonist with vasopressin receptors in the septum of the rat brain. Synapse 2:205-211; 1988.
17. Elalouf, J. M.; DiStefano, A.; DeRouffignac, C. Sensitivities of rat kidney thick ascending limbs and collecting ducts to vasopressin in vivo. Proc. Natl. Acad. Sci. USA 83:2276-2280; 1986.
18. Fahrenholz, F.; Boer, R.; Crause, P.; Fritzsch, G.; Grzonka, Z. Interactions of vasopressin agonists and antagonists with membrane receptors. Eur. J. Pharmacol. 100(1):47-58, 1984.
19. Gillies, G. E.; Linton, E. A.; Lowry, P. J. Corticotropin releasing activity of the new corticotropin releasing factor is potentiated several fold by vasopressin. Nature 299:355-356; 1982.
20. Guillon, G. Vasopressin, oxytocin and angiotensin receptors in mammals. Ann. Endocrinol. (Paris) 50(5):425-433; 1989.
21. Handles, J. S.; Orloff, J. Antidiuretic hormone. Annu. Rev. Physiol. 43:611-624; 1981.
22. Horwitz, K. B.; McGuire, W. L. Specific progesterone receptors in human breast cancer. Steroids 25(4):97-505; 1975.
23. Jard, S. Membrane receptors. In: Kleinzeller, A., ed. Current topics in membrane and transport. vol. 18. New York: Academic Press; 1983:255-285.
24. Jard, S.; Gaillard, R. C.; Guillon, G.; et al. Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypohysis. J. Pharmacol. Exp. Ther. 30:171-177; 1986.
25. Kasting, N. W.; Cooper, K. E.; Veale, W. L. Antipyresis following perfusion of brain sites with vasopressin. Experientia 35:208-209; 1979.
26. Keppens, S.; DeWulf, H. The activation of liver glycogen phosphorylase by vasopressin. FEBS Lett. 51:29-33; 1975.
27. Moguilewsky, M.; Philibert, D. RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J. Steroid Biochem. 20:271-276; 1984.
28. 1a arginine vasopressin receptor. Nature 356:523-526; 1992.
29. Muller, M.; Renkawitz, R. The glucocorticoid receptor. Biochim. Biophys. Acta 1088:171-182; 1991.
30. Mullick, A.; Katzenellenbogen, B. S. Antiprogestin-receptor complexes: Differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells. Biochim. Biophys. Res. Commun. 135(1):90-97; 1986.
31. Nadel, U.; Zakut, R.; Shani, M.; Neuman, S.; Levy, Z.; Yaffe, D. The nucleotide sequence of the rat cytoplasmic β-actin gene. Nucleic Acids Res. 11(6):1759-1771; 1983.
32. Okret, S.; Mikstrom, A. C.; Wrange, O.; Andersson, B.; Gustafsson, J. A. Monoclonal antibodies against the rat liver glucocorticoid receptor. Proc. Natl. Acad. Sci. 81(6):1609-1613; 1984.
33. Philibert, D. RU38486: An original multifaceted antihormone in vivo. In: Agarwal, M. K., ed. Adrenal steroid antagonism. Berlin, Germany: Walter de Gruyter and Co.; 1984:77-101.
34. Phillips, P. A.; Abrahams, J. M.; Kelly, J.; et al. Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist. Neuroscience 27(3) 749-761; 1988.
35. Pittman, Q. J.; Veale, W. L.; Lederis, K. Central neurohypophyseal pathways: Interactions with endocrine and other autonomie functions. Peptides 5:515-520; 1982.
36. Poulin, P.; Lederis, K.; Pittman, Q. J. Subcellular localization and characterization of vasopressin binding sites in the ventral septal area, lateral septum and hippocampus of the rat brain. J. Neurochem. 50:889-898; 1988.
37. Reul, J. M.; Pearce, P. T.; Funder, J. W.; Krozowski, Z. S. Type I and type II corticosteroid receptor gene expression in the rat: Effect of adrenalectomy and dexamethasone administration. Mol. Endocrinol. 3(10):1674-1680; 1989.
38. Rivier, C.; Vale, W. Interaction of corticotropin-releasing factor with arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113:939-942; 1983.
39. Sambrook, J.; Fritsch, E. F.; Maniatis, T. Extraction, purification and analysis of mRNA from eukaryotic cells. In: Nolan, C., ed. Molecular cloning: A laboratory manual. 2nd ed. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1989:7.43-7.48.
40. 1-type vasopressin receptors in rat brain septum: Binding characteristics and effects on inositol phospholipid metabolism. J. Neurosci. 8:1671-1677; 1988.
41. Stephens, L. R.; Logan, S. D. Arginine-vasopressin stimulates inositol phospholipid metabolism in rat hippocampus. J. Neurochem. 46:649-651; 1986.
42. 1-vasopressin receptors. Mol. Cell. Neurosci. 1:117-120; 1990.
43. 1-vascular vasopressin receptors. Regul. Pept. 45:79-84; 1993.
44. 1a receptor gene expression. Soc. Neurosci. Abstr. 20:386.15; 1994.
45. Wittner, M.; DiStefano, A.; Wangemann, P.; et al. Differential effects of ADH on sodium, chloride, potassium, calcium and magnesium transport in cortical and medullary thick ascending limbs of mouse nephron. Pfluegers Arch. 412:516-523; 1988.